These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11170970)
21. Quality of life evaluation in patients with HIV-I infection: the impact of traditional medicine in Zimbabwe. Sebit MB; Chandiwana SK; Latif AS; Gomo E; Acuda SW; Makoni F; Vushe J Cent Afr J Med; 2000 Aug; 46(8):208-13. PubMed ID: 11317592 [TBL] [Abstract][Full Text] [Related]
22. The validity of EQ-5D US preference weights in liver transplant candidates and recipients. Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831 [TBL] [Abstract][Full Text] [Related]
23. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688 [TBL] [Abstract][Full Text] [Related]
24. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ; Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012 [TBL] [Abstract][Full Text] [Related]
25. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062 [TBL] [Abstract][Full Text] [Related]
26. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262 [TBL] [Abstract][Full Text] [Related]
27. Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection. Quang-Cantagrel ND; Wallace MS; Ashar N; Mathews C Eur J Pain; 2001; 5(4):415-20. PubMed ID: 11743707 [TBL] [Abstract][Full Text] [Related]
28. Quality of life and HIV: current assessment tools and future directions for clinical practice. Grossman HA; Sullivan PS; Wu AW AIDS Read; 2003 Dec; 13(12):583-90, 595-7. PubMed ID: 14959693 [TBL] [Abstract][Full Text] [Related]
29. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort. Braitstein P; Montessori V; Chan K; Montaner JS; Schechter MT; O'Shaughnessy MV; Hogg RS AIDS Care; 2005 May; 17(4):505-15. PubMed ID: 16036236 [TBL] [Abstract][Full Text] [Related]
30. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F; Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822 [TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in individuals infected with HIV in the era of HAART. Miners AH; Sabin CA; Mocroft A; Youle M; Fisher M; Johnson M HIV Clin Trials; 2001; 2(6):484-92. PubMed ID: 11742437 [TBL] [Abstract][Full Text] [Related]
33. Oral health-related quality of life among low-income adults living with HIV. Tomar SL; Pereyra M; Metsch LR J Public Health Dent; 2011; 71(3):241-7. PubMed ID: 21972465 [TBL] [Abstract][Full Text] [Related]
34. Modification of medical outcome study (MOS) instrument for quality of life assessment & its validation in HIV infected individuals in India. Kohli RM; Sane S; Kumar K; Paranjape RS; Mehendale SM Indian J Med Res; 2005 Oct; 122(4):297-304. PubMed ID: 16394320 [TBL] [Abstract][Full Text] [Related]
35. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Weinfurt KP; Willke RJ; Glick HA; Freimuth WW; Schulman KA Med Care; 2000 Apr; 38(4):404-10. PubMed ID: 10752972 [TBL] [Abstract][Full Text] [Related]
36. [Reliability and validity of the Spanish version of the MOS-SF-30 to assess the health related quality of life in people infected by HIV]. Remor E Aten Primaria; 2003 Jun; 32(1):15-22. PubMed ID: 12812686 [TBL] [Abstract][Full Text] [Related]
37. Predictors of oral health quality of life in HIV-1 infected patients attending routine care in Australia. Jeganathan S; Batterham M; Begley K; Purnomo J; Houtzager L J Public Health Dent; 2011; 71(3):248-51. PubMed ID: 21972466 [TBL] [Abstract][Full Text] [Related]
38. Chemosensory function and diet in HIV-infected patients. Mattes RD; Wysocki CJ; Graziani A; MacGregor RR Laryngoscope; 1995 Aug; 105(8 Pt 1):862-6. PubMed ID: 7630301 [TBL] [Abstract][Full Text] [Related]
39. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. Spanish MOS-HIV and MQOL-HIV Validation Group. Medical Outcomes Study HIV Health Survey. Badia X; Podzamczer D; Garcia M; López-Lavid C C; Consiglio E AIDS; 1999 Sep; 13(13):1727-35. PubMed ID: 10509575 [TBL] [Abstract][Full Text] [Related]
40. Validation of the Medical Outcomes Study HIV Health Survey as a measure of quality of life in HIV-infected patients in Singapore. Paton NI; Chapman CA; Chan SP; Tan KM; Leo YS; Aboulhab J; Soh CH Int J STD AIDS; 2002 Jul; 13(7):456-61. PubMed ID: 12171664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]